Interesting assessment of adoption of continuous API synthesis, featuring Snapdragon Chemistry

Pharmaceutical Technology article, featuring Snapdragon Chemistry and Tim Jamison (our President/CEO), provides an interesting assessment of the adoption of continuous API synthesis. This includes that early adopters and fast followers drive change, flow chemistry provides an expanding toolbox to chemists, the lack of expertise in flow, and issues related to regulation and infrastructure.